These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 27520885)

  • 1. Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis.
    Yarborough BJ; Stumbo SP; Janoff SL; Yarborough MT; McCarty D; Chilcoat HD; Coplan PM; Green CA
    Drug Alcohol Depend; 2016 Oct; 167():49-56. PubMed ID: 27520885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties.
    Janoff SL; Perrin NA; Coplan PM; Chilcoat HD; Campbell CI; Green CA
    BMC Pharmacol Toxicol; 2016 May; 17(1):21. PubMed ID: 27177423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription histories and dose strengths associated with overdose deaths.
    Hirsch A; Proescholdbell SK; Bronson W; Dasgupta N
    Pain Med; 2014 Jul; 15(7):1187-95. PubMed ID: 25202775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study.
    Lundstrom EW; Dai Z; Groth CP; Hendricks B; Winstanley EL; Abate M; Smith GS
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):4. PubMed ID: 38178238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.
    Mattson CL; O'Donnell J; Kariisa M; Seth P; Scholl L; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):945-951. PubMed ID: 30161105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
    JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for severe respiratory depression from prescription opioid overdose.
    Fox LM; Hoffman RS; Vlahov D; Manini AF
    Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescribing Patterns Before Fatal Opioid Overdose.
    Abbasi AB; Salisbury-Afshar E; Berberet CE; Layden JE; Pho MT
    Am J Prev Med; 2020 Feb; 58(2):250-253. PubMed ID: 31959322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
    Cheatle MD
    Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009.
    Johnson EM; Lanier WA; Merrill RM; Crook J; Porucznik CA; Rolfs RT; Sauer B
    J Gen Intern Med; 2013 Apr; 28(4):522-9. PubMed ID: 23070654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy.
    Miller M; Barber CW; Leatherman S; Fonda J; Hermos JA; Cho K; Gagnon DR
    JAMA Intern Med; 2015 Apr; 175(4):608-15. PubMed ID: 25686208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.
    Ray WA; Chung CP; Murray KT; Hall K; Stein CM
    JAMA; 2016 Jun; 315(22):2415-23. PubMed ID: 27299617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring trends in benzodiazepine-positive fatal drug overdoses in Tennessee, 2019-2021.
    Moses J; Korona-Bailey J; Mukhopadhyay S
    Ann Med; 2023; 55(2):2287194. PubMed ID: 38039554
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.